Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M White

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
Iscience|April 11, 2022
Mono- and combinational drug therapies for global viral pandemic preparednessAleksandr Ianevski, Rouan Yao, Ronja M Simonsen, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2021
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs"Shawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
Plos Neglected Tropical Diseases|July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana LectinEvelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Plos Neglected Tropical Diseases|April 14, 2017
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infectionElizabeth A Nelson, Julie Dyall, Thomas Hoenen, et al.
Microorganisms|April 3, 2021
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In VivoCourtney L Finch, Julie Dyall, Shuang Xu, et al.
The Journal of Infectious Diseases|June 26, 2018
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell CulturesJulie Dyall, Elizabeth A Nelson, Lisa Evans DeWald, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
Iscience|April 11, 2022
Mono- and combinational drug therapies for global viral pandemic preparednessAleksandr Ianevski, Rouan Yao, Ronja M Simonsen, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2021
Erratum for Herring et al., "Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs"Shawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
Plos Neglected Tropical Diseases|July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana LectinEvelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Plos Neglected Tropical Diseases|April 14, 2017
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infectionElizabeth A Nelson, Julie Dyall, Thomas Hoenen, et al.
Microorganisms|April 3, 2021
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In VivoCourtney L Finch, Julie Dyall, Shuang Xu, et al.
The Journal of Infectious Diseases|June 26, 2018
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell CulturesJulie Dyall, Elizabeth A Nelson, Lisa Evans DeWald, et al.
Pageof 8